Acadia Pharmaceuticals ACAD Increase (Decrease) in Other Operating Assets

Increase (Decrease) in Other Operating Assets at other companies

LivaNovaLIVN

$4.2M+165%

Skyline ChampionSKY

-$17.54M-132%

LKQLKQ

$23M+608%

BankUnitedBKU

$29.48M-23.7%

MYR GroupMYRG

-$2.96M+68.9%

NNN REITNNN

$792K+160%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's increase (decrease) in other operating assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's increase (decrease) in other operating assets?: Acadia Pharmaceuticals (ACAD) reported increase (decrease) in other operating assets of $32K in Q1 2026.
How has Acadia Pharmaceuticals's increase (decrease) in other operating assets changed year-over-year?: Acadia Pharmaceuticals's increase (decrease) in other operating assets decreased by 94.5% year-over-year, from $585K to $32K.